MAPK1 and breast cancer: The Ras-MAPK pathway can also act as a tumor suppressor by inducing cell senescence and apoptosis, and as a MAPK subfamily, active ERK is abnormally elevated in breast cancer cells during development and progression (28), aberrant ERK activation leads to proliferation and apoptosis inhibition in breast cancer (29).